Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation by Paulmann, N. et al.
Intracellular Serotonin Modulates Insulin Secretion from
Pancreatic b-Cells by Protein Serotonylation
Nils Paulmann1,2, Maik Grohmann1,2, Jo¨rg-Peter Voigt3, Bettina Bert3, Jakob Vowinckel1,2, Michael
Bader4, Masˇa Skelin5, Marko Jevsˇek5, Heidrun Fink3, Marjan Rupnik5, Diego J. Walther1*
1Department of Human Molecular Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany, 2Department of Biology, Chemistry, and Pharmacy, Free
University Berlin, Berlin, Germany, 3 Institute of Pharmacology and Toxicology of the School of Veterinary Medicine, Free University Berlin, Berlin, Germany, 4 Laboratory of
Molecular Biology of Peptide Hormones, Max Delbru¨ck Center for Molecular Medicine, Berlin, Germany, 5 Institute of Physiology of the Medical Faculty, University of
Maribor, Maribor, Slovenia
Abstract
While serotonin (5-HT) co-localization with insulin in granules of pancreatic b-cells was demonstrated more than three decades
ago, its physiological role in the etiology of diabetes is still unclear. We combined biochemical and electrophysiological analyses
of mice selectively deficient in peripheral tryptophan hydroxylase (Tph12/2) and 5-HT to show that intracellular 5-HT regulates
insulin secretion. We found that these mice are diabetic and have an impaired insulin secretion due to the lack of 5-HT in the
pancreas. The pharmacological restoration of peripheral 5-HT levels rescued the impaired insulin secretion in vivo. These
findings were further evidenced by patch clamp experiments with isolated Tph12/2 b-cells, which clearly showed that the
secretory defect is downstream of Ca2+-signaling and can be rescued by direct intracellular application of 5-HT via the clamp
pipette. In elucidating the underlying mechanism further, we demonstrate the covalent coupling of 5-HT by transglutaminases
during insulin exocytosis to two key players in insulin secretion, the small GTPases Rab3a and Rab27a. This renders them
constitutively active in a receptor-independent signaling mechanism we have recently termed serotonylation. Concordantly, an
inhibition of such activating serotonylation in b-cells abates insulin secretion. We also observed inactivation of serotonylated
Rab3a by enhanced proteasomal degradation, which is in line with the inactivation of other serotonylated GTPases. Our results
demonstrate that 5-HT regulates insulin secretion by serotonylation of GTPases within pancreatic b-cells and suggest that
intracellular 5-HT functions in various microenvironments via this mechanism in concert with the known receptor-mediated
signaling.
Citation: Paulmann N, Grohmann M, Voigt J-P, Bert B, Vowinckel J, et al. (2009) Intracellular Serotonin Modulates Insulin Secretion from Pancreatic b-Cells by
Protein Serotonylation. PLoS Biol 7(10): e1000229. doi:10.1371/journal.pbio.1000229
Academic Editor: Steve O’Rahilly, University of Cambridge, United Kingdom
Received July 15, 2009; Accepted September 18, 2009; Published October 27, 2009
Copyright:  2009 Paulmann et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work is funded by the Max-Planck-Society (DFG-SFB577). The funders had no role in study design, data collection and analysis, decision to publish,
or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Abbreviations: 5-HT, serotonin; 5-HTP, 5-hydroxytryptophan; HVA, high voltage activation; LVA, low voltage activation; MDC, monodansylcadaverine; MODY,
maturity-onset diabetes of the young; SERT, 5-HT reuptake transporter; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; TGase, transglutaminase;
Tph12/2, tryptophan hydroxylase 1 knockout mice; wt, wild-type; VACC, voltage-activated Ca2+ channels.
* E-mail: dwalther@molgen.mpg.de
Introduction
Diabetes mellitus, primarily defined as a chronic hyperglycemia
giving rise to risk of microvascular damage, is one of the most
serious metabolic disorders by means of 171 million people
affected worldwide in 2000 and a projected 366 million by 2030
[1]. A comprehensive understanding of the molecular processes
underlying the development of diabetes is of clinical and economic
importance.
Several animal models for type 1 and 2 diabetes mellitus
(T1DM, T2DM) and maturity-onset diabetes of the young
(MODY) have been generated in order to shed light on the
etiology of this disease [2–4], but many regulatory aspects of
insulin secretion are poorly understood, as the machinery involved
is complex. One issue that has eluded researchers for more than
three decades concerns the role of serotonin (5-hydroxytrypta-
mine; 5-HT) in b-cells [5,6]. 5-HT is synthesized within b-cells [7],
it is stored together with insulin in their secretory b-granules [8],
and it is co-released when pancreatic islets are stimulated with
glucose [9,10]. For these reasons, insulin secretion is currently
often monitored in cell models, such as insulinoma cells or freshly
isolated islets, using 5-HT as a surrogate measure because of its
rapid and reliable detection by electrophysiological techniques
[7,9,10]. Nevertheless, the physiological meaning of 5-HT co-
localization with insulin in b-cells remains a mystery.
A key to the understanding are recent advances in our
knowledge of intracellular 5-HT functions, for instance during
mammary gland involution, primary hemostasis, or liver regen-
eration [11–13], which have led to the concept of ‘‘microser-
otonergic systems’’ in peripheral tissues in contrast to the
traditional view of 5-HT as a pleiotropic hormone. Studies on
tryptophan hydroxylase 1 knockout mice (Tph12/2), which are
deficient in peripheral 5-HT but have normal 5-HT levels in the
brain, identified the ‘‘serotonylation’’ of small GTPases as a
receptor-independent, intracellular signaling mechanism of mono-
amines [13]. In thrombocytes, intracellular Ca2+ mobilization and
monoamine accumulation in the cytoplasm trigger vesicular
exocytosis through a constitutively activating covalent binding of
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5-HT to GTPases of the Rho and Rab families, in a reaction that
is conferred by the Ca2+-dependent transglutaminases (TGases)
[13]. This process has been found also in smooth muscle cells,
where the serotonylation of RhoA triggers their mitogenesis [14],
and in platelets, where the serotonylation of Rab4 triggers the
internalization of the 5-HT reuptake transporter (SERT) [15].
In addition, it has been suggested that TGase2 is involved in the
glucose-stimulated insulin release from b-cells, based on the
finding that TGase22/2 mice are glucose intolerant [16].
Furthermore, GTPases are crucial regulatory components in
insulin secretion [17–19]. This prompted us to investigate
serotonylation of GTPases as a modulatory mechanism in insulin
secretion.
Results/Discussion
Tph12/2 Mice Lack 5-HT in the Pancreas and Are
Diabetic
Pancreatic 5-HT levels in Tph12/2 mice only reach 10% of
the wild-type (wt) mean (Figure 1A) and neither pancreas mass
(Tph1+/+: 150630 mg, n=27; Tph12/2: 160640 mg, n=30)
nor morphology, nor the number and size of islets differ between
Tph12/2 and wt mice (Figure 1B and 1C). Concordant to the
lack of peripheral 5-HT in Tph12/2mice, they are hypersensitive
to the satiety mediating effect of systemically applied 5-HT (Figure
S1). In addition, the basal blood glucose concentrations in freely
feeding mice are significantly elevated relative to those in wt mice
(Figure 1D), while none of the other pancreatic markers in
extensive serological screenings are altered in Tph12/2 mice
(Table S1). The glucose levels are elevated as early as 14 d after
birth in Tph12/2 mice and are maintained into young
adulthood, indicating glucose intolerance. Concordantly, fasted
Tph12/2 mice exhibited significantly higher blood glucose
concentrations than wt animals in glucose tolerance tests
(Figure 1E). Young adult Tph12/2 mice also present a mild
insulin resistance (Figure 1F).
The glucose intolerance is comparable to the T2DM phenotype
of 5-HT2C receptor knockout mice [20] and occurs at a surprising
young age between postnatal Days 3 and 14 (Figure 1D). Glucose
tolerance tests with simultaneous glucose and insulin measurements
then revealed a primary b-cell dysfunction in glucose-induced
insulin secretion (Figure 2). The rise in blood glucose was
significantly higher in the Tph12/2 mice 30 min after a glucose
load (Figure 2A) and was not proportional to the initially elevated
glucose level (difference significantly higher). The glucose load was
also accompanied with a significantly shortened insulin secretion
(Figure 2B), best seen at the difference. Therefore, glucose to insulin
ratios (Figure 2C) were significantly increased in Tph12/2 before
and after the glucose load, which indicates a b-cell dysfunction. This
reaction was also observed in younger animals of both mixed and
inbred genetic backgrounds (Figure S2). Moreover, the fasting
glucose levels were increased by around 20% to 9.7 mM in the
Tph12/2 aged 64–70 wk (Figure 2A). In conclusion, Tph12/2
Figure 1. Pancreata of Tph12/2 mice have a normal morphol-
ogy but lack 5-HT, which results in hyperglycemia and insulin
resistance. (A) 5-HT contents in Tph12/2 and wt mice show, that
Tph12/2 pancreata contain only around 10% of the wt mean. *p,0.05;
n= 6. (B) Combined stacks of confocal images of pancreas slices
spanning 10 mm with anti-insulin-stained islets (green) and anti-S100-
stained ductal structures (red) at postnatal day 3 (P3) reveal no
difference between the genotypes; scale bar = 70 mm. (C) Individual
islets do not differ in morphometric analysis (Tph12/2: n= 29; wt:
n= 30). (D) Basal blood glucose concentration in freely feeding Tph12/2
mice are significantly reduced at P3 (Tph12/2: n=20; wt: n=11) and
elevated at P14 (n=5) and in adulthood (n=6) compared to wt
littermates. *p,0.05. (E) Glucose tolerance tests with fasted wt and
Tph12/2 mice show impaired glucose tolerance of the latter. *p,0.05;
n=6. (F) Insulin tolerance tests with Tph12/2 and wt mice. *p,0.05;
n=6. For (A) and (C–F), data are means 6 SEM.
doi:10.1371/journal.pbio.1000229.g001
Author Summary
Diabetes is the most prevalent metabolic disease and one
that affects individuals of every social and economic status.
The disease can arise as a result of reduced secretion of
insulin from pancreatic b-cells or reduced action of insulin
on its target organs. Therefore, understanding how to
prevent and treat diabetes requires an extensive knowl-
edge of the regulation of insulin secretion. In this study,
we identify the hormone serotonin as a new regulator of
insulin secretion and thereby attribute a function to the
co-localization of serotonin and insulin in pancreatic b-cells
that was first observed 30 years ago but until now not
understood. We first demonstrate that a lack of serotonin
in b-cells of transgenic mice leads to reduced insulin
secretion and diabetes mellitus and that pharmacological
replenishment of serotonin rescues insulin secretion in
these mice. Interestingly, serotonin mainly acts not as an
intercellular signaling molecule via its traditional surface
receptors but intracellularly via regulation of the activity of
target proteins through covalent coupling of serotonin to
them. This coupling, called serotonylation, activates
specific small GTPases, which in turn promote glucose-
mediated insulin secretion. Adding this receptor-indepen-
dent signaling mechanism to the multifarious regulatory
functions of serotonin, we hypothesize that protein
serotonylation modulates physiological secretion process-
es in all serotonin-containing tissues.
Serotonylation Modulates Insulin Exocytosis
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mice are clearly diabetic, but the classification of the specific subtype
of diabetes is difficult due to the lack of standardized mice-specific
criteria. Nevertheless, such a phenotype, a primary b-cell
dysfunction in glucose-induced insulin secretion with a monogenic
inheritance and an early onset but with no loss of b-cell mass, would
be classified as MODY in humans [21]. Therefore, one might
speculate that TPH1 is a possible candidate gene for this metabolic
disorder in humans, especially as a genetic diagnosis in at least 11%
of European and as many as 70%–80% of Asian families with a
diagnosis of MODY cannot be made, indicating that additional
MODY-related genes need to be identified [22–24]. Nonetheless,
follow-up screening of the TPH1 gene of unclassified MODY
patients is to be performed in order to support this hypothesis.
Interestingly, Tph12/2 mice thrive normally [13,25], and they
live as long as their wt littermates (mean life expectancy: 113 wk;
n=37; x2 = 0.98). We consider these findings to be particularly
important, since diabetes mellitus, if left untreated, significantly
curtails life expectancy [21,26]. Especially the development of
secondary damage like cardiovascular disease is the major cause for
morbidity and mortality in diabetes. We have previously demon-
strated that Tph12/2 mice are less prone to succumb to vessel
occlusion in experimental thromboembolism and thrombosis due to
a reduced primary haemostatic response [13]. This beneficial
protective side effect of the lack of 5-HT decreases cardiovascular
complications in Tph12/2 mice and seems to mild the severity of
their diabetes. The general differences between mouse and man
hamper a direct translation of findings between these species.
Nevertheless, one might speculate that therapeutic peripheral 5-HT
reduction specifically in thrombocytes [13,27], together with blood
glucose management, can also ameliorate vascular disease and its
complications in diabetic patients. This concept for future work
could possibly open new avenues to improve quality of life and to
prolong life expectancy of diabetic patients.
Extra- and Intracellular 5-HT Modulates Insulin Secretion
in Opposing Directions
To further elucidate the role of 5-HT in diabetes, we took
advantage of well-established pharmacological possibilities for
Figure 2. Intra- and extracellular 5-HT modulates insulin secretion in opposing directions. (A–C) Diabetes mellitus and b-cell dysfunction
in Tph12/2 mice aged 64 to 70 wk and rescue with 5-HTP. Glucose tolerance test with simultaneous blood glucose (A) and serum insulin (B)
measurements. Glucose to insulin ratios (C) are significantly increased in Tph12/2 without 5-HTP treatment before and after the glucose load.
*p,0.05; n= 8 (wt and Tph12/2 + 5-HTP) and n=6 (Tph12/2). (D) Pargyline induces hyperglycemia in wt mice. After a meal of 60 min, mice were
treated with pargyline (75 mg kg21) and blood glucose was measured immediately and after additional 60 min. *p,0.05; n=6. (E) Pargyline
treatment substantially elevated insulin secretion in wt mice. Mice were treated as described in (D). *p,0.05; n= 6. (F) Glucose tolerance test of
Tph12/2 and wt mice with systemic 5-HT pre-treatment. *p,0.05; n= 6. (G) Extracellular 5-HT inhibits insulin secretion in MIN-6, INS-1, and RINm5F
insulinoma cells. Cells were treated with 5-HT (500 mM) at the beginning of a 60 min secretion period. Insulin secretion is normalized to glucose-
induced control cells. *p,0.05; n=4. (H) Insulin secretion of RINm5F cells with or without glucose and 5-HTP (500 mM; 3 h) or pargyline (20 mM; 3 h).
*p,0.05; n=3. All data are presented as means 6 SEM.
doi:10.1371/journal.pbio.1000229.g002
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manipulating intracellular 5-HT levels (Figure S3). Application of
5-hydroxytryptophan (5-HTP), the immediate precursor of 5-HT
(Figure S3A), increases the intracellular 5-HT level, bypassing the
rate-limiting biosynthesis step [6,11,28]. Indeed, this treatment
normalized the blood glucose levels and largely rescued the
deficient insulin secretion in the Tph12/2 mice (Figure 2A and
2B).
In addition to the use of 5-HTP to increase intracellular 5-HT,
pargyline, which blocks the 5-HT catabolism [6], can also be used
for this purpose (Figure S3A). Systemic application of pargyline
leads to a rapid hypoglycemic and hyperinsulinemic response in
mice [29], suggesting that intracellular 5-HT enhances insulin
secretion. If intracellular 5-HT plays such an enhancing role in
insulin secretion, then pargyline application should have no effects
in Tph12/2 mice, which lack 5-HT. Concordantly, pargyline
induced hypoglycemia (Figure 2D) and an acute rise in plasma
insulin (Figure 2E) exclusively in wt but not in Tph12/2 mice.
We then investigated glucose homeostasis after a systemic 5-HT
application 30 min prior to the glucose load in fasted mice, in
order to explore the extracellular role of 5-HT. In these tests, mice
of both genotypes had largely elevated blood glucose levels
(Figure 2F) compared to mice without pre-treatment (Figure 1E).
This suggests that extracellular 5-HT has an inhibitory influence
on insulin secretion as noted previously [30], most likely acting via
the sole known 5-HT receptor of b-cells, the 5-HT1A receptor.
The effect of extracellular 5-HT on insulin secretion of b-cells was
further investigated using the insulin-secreting cell lines MIN-6,
INS-1, and RINm5F [31,32], which all exhibit responsiveness
to glucose-stimulation (Figure 2G). Indeed, extracellular 5-HT
inhibited glucose-induced insulin secretion in all three b-cell
lines. One has to take into account that b-cells take up 5-HT
via the plasma membrane SERT into the cytoplasm [7,9,10].
Therefore, 5-HT might also partially act intracellularly in this
experiment. But since the incubation with 5-HT was short, its
action can be attributed mostly to extracellular mechanisms.
Moreover, elevated levels of intracellular 5-HT would rather
not inhibit but enhance the glucose-mediated insulin secretion, as
seen by 5-HTP and pargyline treatment of insulinoma cells
(Figure 2H). The stronger effect of 5-HTP found in these tests is
supported by our finding that 5-HTP rises the intracellular 5-HT
concentration to a higher extent than pargyline treatment (Figure
S4). High intracellular 5-HT levels seem to be involved in the
control of basal secretion as well, as 5-HTP slightly enhances
insulin secretion from RINm5F cells also under non-stimulatory
conditions (Figure 2H). The hyperinsulinemic effect of the above-
mentioned compounds that increase intracellular 5-HT levels is in
accordance with the results in vivo (Figure 2B and 2E), further
supporting a crucial role for intracellular 5-HT as a modifier of
insulin secretion.
Impaired Secretory Activity from b-Cells in Adult
Tph12/2 Mice
To directly test the hyposecretory phenotype, we monitored
secretion from Tph12/2 and wt b-cells by whole-cell patch-clamp
measurements of membrane capacitance in fresh pancreas slices,
taking advantage of the fast time resolution of electrophysiological
techniques [33]. The resting membrane capacitance, electrical
coupling between neighboring cells, and the amplitude of high
voltage-activated Ca2+ channels (VACC) did not differ signifi-
cantly between the Tph12/2 and wt b-cells (Figure S5).
Nevertheless, the secretory response in Tph12/2 b-cells was
significantly impaired when triggered by depolarization trains and
measured as a cumulative increase in membrane capacitance
(Figure 3A). Impaired secretion can also be due to impaired
function of high VACC, but we found that peak amplitude of high
voltage-activated (HVA) Ca2+ currents were not significantly
different (Figure S5A). However the amplitude of low voltage-
activated (LVA) Ca2+ currents was prominently increased in
Tph12/2 compared to wt b-cells (Figure S5B). The b-cell
electrical activity in Tph12/2 cells seems to be activating at lower
glucose concentration (Figure 3B), which likely results from the
increased LVA Ca2+ current amplitudes we observe in these mice
(Figure S5B), because increased T-type currents are known to
lower the threshold for action potential firing in insulinoma cells
(INS-1) and non-obese diabetic mice [34,35]. As the HVA current
amplitudes were not significantly impaired, we conclude that the
secretory impairment is not due to lower Ca2+ influx. Next we
tested the impairment of the secretory response downstream of the
Ca2+ influx. Slow UV photo-release of caged Ca2+ increased
Figure 3. Impaired exocytosis of Tph12/2 b-cells and rescue
with 5-HT. (A) A train of 50 depolarizing pulses from 280 to +10 mV
for 40 ms at 10 Hz induced changes in the membrane capacitance of
wt (n= 24) and Tph12/2 (n= 19) b-cells. Data are shown as means 6
SEM. (B) Representative current-clamp recordings of the electrical activity
of wt and Tph12/2 b-cells in pancreas tissue slices. The slices were
perfused with solutions containing different glucose concentrations as
indicated in the bar below the traces. (C) Representative membrane
capacitance response of isolated wt and Tph12/2 b-cells (top panel)
stimulated by ramp [Ca2+]i change induced by slow photo-release of caged
Ca2+ (bottom panel). The impaired component exocytosis has been
partially rescued by extracellular 5-HTP (500 mM, 24 h) and completely
restored by pipette intracellular dialysis with 5-HT.
doi:10.1371/journal.pbio.1000229.g003
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intracellular Ca2+, which peaked after about 5 s and reached a
steady state value after 10 s (Figure 3C, lower panel). When free
Ca2+ exceeded about 2 mM, a biphasic response in membrane
capacitance was triggered. The amplitude of the fast component
was comparable in both phenotypes, whereas the amplitude of the
slow component was significantly reduced in Tph12/2 (Figure 3C,
upper panel; for statistics see Figure S6). To test the direct role of
5-HT, we either incubated isolated b-cells with 5-HTP for 24 h or
infused 5-HT through the patch pipette. While 5-HTP treatment
partially restores the capacitance response, infusion of 5-HT
completely rescued the reduced secretory phenotype (Figure 3C,
upper panel). We conclude that the secretory lesion does not
involve the coupling of the secretory machinery to either VACCs
or Ca2+ sensors but interferes with the recruitment and exocytosis
of the dense-core vesicles. The process is fast since the cell dialysis
with 5-HT rescues the phenotype within a few minutes.
Serotonylation Modulates Insulin Secretion
In thrombocytes, intracellular 5-HT serves as a substrate for
protein serotonylation (Figure 4A), which modifies the trafficking
of proaggregatory a-granules and results in their exocytosis [13].
Thus, we asked whether serotonylation is also involved in
the b-granule transport and exocytosis. We first confirmed that
RINm5F and b-TC3 cells readily take up [3H]-5-HT (Figure 4B
and 4C), as previously described for other insulinoma cell lines and
islets [7,9,10]. The uptake has a similar kinetic in both cell lines,
leveling off approximately 90 min after addition of [3H]-5-HT.
Under these conditions, we detected covalent [3H]-5-HT
incorporation into the protein fraction in both cell lines, revealing
a massive serotonylation of proteins. This serotonylation was
sensitive to the potent TGase inhibitor cysteamine in both cell
lines, demonstrating that the reaction is TGase-dependent. More
importantly, cysteamine also curtailed the glucose-stimulated
insulin secretion in MIN-6 insulinoma cells (Figure 4D), as well
as in INS-1 and RINm5F cells (Figure S7). These results are in line
with the reduced insulin secretion of primary b-cells from rat
treated with either the TGase inhibitor monodansylcadaverin
(MDC) [36] or cysteamine [37] and the reduced insulin release
and the MODY phenotype of TGase22/2 mice [16]. Thus,
protein serotonylation is unequivocally detectable in b-cells and it
modulates insulin secretion. Nonetheless, the further elucidation of
signaling cascades regulating or interfering with this novel
Figure 4. Inhibition of protein serotonylation reduces insulin secretion. (A) Scheme of protein serotonylation of glutamine residues by TGase.
Cysteamine (CTA) and monodansylcadaverin (MDC) are potent inhibitors of TGases. (B and C) Uptake and protein incorporation of [3H]-5-HT in b-TC3 (B)
and RINm5F cells (C) in the presence of CTA (500 mM; 3 h). *p,0.05; n=3. (D) Insulin secretion from MIN-6 cells in the presence of CTA (500 mM; 3 h).
*p,0.05; n=4. (E) Proteasomal degradation of serotonylated proteins in RINm5F cells at different glucose concentrations in the presence or absence of
the proteasomal inhibitor LLnL (50 mM; 3 h).*p,0.05; n=4. (F) Immunoblot of serotonylated (5-HT) and total (5xHis) 6xH-Rab3a (white arrowhead) and
6xH-Rab27a (black arrowhead) prepared from glucose-stimulated RINm5F cells treated with 100 mM MDC, 200 mM CTA, or vehicle. Shown is one
representative experiment out of three repetitions. (G) Quantification by Ni-NTA pull-downs of 6xH-Rab3a and 6xH-Rab27a from glucose-stimulated
RINm5F cells incubated with [3H]-5-HT and either 50 mM LLnL or vehicle. *p,0.05; n=3. Vector, vector-transfected control. For (B–E) and (G), data are
means 6 SEM.
doi:10.1371/journal.pbio.1000229.g004
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mechanism is an obvious issue that has to be clarified in follow-up
studies.
Unexpectedly, the [3H]-5-HT incorporation rates in glucose-
stimulated and non-stimulated RIN5mF cells did not differ
(Figure 4E). However, it is now well-established that small
GTPases constitutively activated by TGases are marked for
proteasomal degradation by ubiquitination [14]. Concordantly,
inhibition of the proteasome with calpain inhibitor I (LLnL)
significantly accumulated serotonylated proteins only in the
presence of glucose (Figure 4E), suggesting that with an increased
insulin secretion, there is a faster cycling between activation by
serotonylation and inactivation by proteasomal degradation.
Rab3a and Rab27a Become Serotonylated during
Glucose-Mediated Insulin Secretion
Previously, GTPases have been found to be targets for
serotonylation in other tissues [13,14], prompting us to test two
GTPases crucially involved in insulin secretion as putative targets
in b-cells; Rab3a regulates replenishment of the ready releasable
pool of b-granules by recruiting calmodulin to the resting pool at
early stages of vesicle transport [38]. Rab27a acts directly in the
targeting of b-granules from the resting pool to the ready
releasable pool at the plasma membrane [19]. To confirm their
serotonylation during insulin secretion, we expressed 6xHis-tagged
Rab3a and Rab27a in RINm5F cells (Figure S8), which express all
components for serotonylation (Figure S9). Indeed, both GTPases
become serotonylated within these cells in a TGase-dependent
manner, as the TGase inhibitors MDC and cysteamine both
blocked this reaction (Figure 4F). In addition, using radiolabeled
[3H]-5-HT, we quantified the serotonylation of these GTPases
(Figure 4G). LLnL enriched serotonylated Rab3a but not Rab27a,
showing that proteasomal degradation is the mechanism of
inactivation of Rab3a, at least at the selected time point, as
shown for serotonylated RhoA [14]. The difference between the
two GTPases could reflect different kinetics of inactivation by
proteasomal degradation, suggesting a high selectivity of this
process. While Rab3a-deficient mice present with glucose
intolerance, transfection of insulinoma cells with constitutively
active Rab3a was shown to inhibit insulin release by accumulating
and retaining the vesicles in the ready releasable pool [17]. Hence,
the continuous secretion seems to demand a rapid cycling of
Rab3a between an active and inactive state. In contrast,
constitutively active Rab27a has been shown to increase insulin
release [39]. Thus, it could be of physiological relevance to
serotonylate Rab27a to a higher extent and stability than Rab3a in
order to promote continuous b-granule exocytosis.
The data presented here suggest a model in which TGase is
activated by the increase of intracellular Ca2+ that occurs upon
glucose stimulation (Figure 5). TGases then use intracellular 5-HT
to serotonylate Rab3a and Rab27a, likely amongst a set of diverse
other yet to be identified target proteins, as suggested by the massive
serotonylation observed in b-cells (Figure 4B and 4C). This renders
them constitutively active and promotes insulin secretion. The
serotonylated GTPases become inactivated by ubiquitin-dependent
proteasomal degradation at different rates, which is analogous to the
recently described inactivation of serotonylated RhoA [14].
This model is in line with the well-known pulsatile insulin
secretion with a frequency of about one to five per minute, which
is accompanied by synchronous intracellular Ca2+ oscillations
[40]. These Ca2+ oscillations that are likely paralleled by
Figure 5. Proposed model of 5-HT-induced exocytosis of b-granules from glucose-stimulated b-cells. The classic sequel of glucose
transport, glucose oxidation and ATP generation, ATP-gated potassium channel closure, membrane depolarisation, and Ca2+ influx via voltage-
dependent calcium channels is represented in the upper part of the scheme. Amongst other functions, Ca2+ activates TGases that serotonylate a
variety of proteins. In the b-cell, Rab3a, and Rab27a, which are crucially involved in the exocytosis of insulin, are target signaling proteins that become
activated by this mechanism. Insulin and 5-HT co-secretion is the consequence. While insulin then exerts its endocrine function, 5-HT acts via an
autocrine/paracrine loop. Initially, high extracellular 5-HT concentrations [5-HT]e attenuate further insulin secretion through 5-HT1A receptors, with
progressive weakening of this effect by the clearance of [5-HT]e via uptake through the plasma membrane SERT. Eventually, [5-HT]i reaches much
higher levels than [5-HT]e, promoting another event of insulin secretion by serotonylation. This 5-HT-dependent cycling between inhibition and
induction might contribute to the well-known oscillating nature of insulin exocytosis from glucose-stimulated b-cells.
doi:10.1371/journal.pbio.1000229.g005
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intracellular 5-HT oscillations fulfill the conditions required for
serotonylation of GTPases [13]. Furthermore, our data are in
accordance with the phenotype of TGase22/2 mice, which also
present a reduced b-cell function [16]. Thus, inactivation of the
catalyzing enzyme TGase2 [16], a lack of the monoamine
substrate for serotonylation (Tph12/2), and the absence of the
protein substrates Rab3a and Rab27a [18,19] all lead to defective
insulin secretion independently. These findings support an
essential function of serotonylation for insulin exocytosis.
The data presented here assign a mechanistic role to the 5-HT
contained in b-granules as a substrate for the serotonylation of
proteins involved in insulin secretion. Our model, in which
signaling protein serotonylation strengthens the function of the
exocytotic machinery, shows striking resemblance to the process in
thrombocytes [13]. Our findings suggest that serotonylation is a
modifier mechanism in the high clinical variability of diabetes and
may have an impact on future therapeutic concepts. If confirmed
in other monoamine-rich cells, such as histaminergic or catechol-
aminergic neurons, this study has not only elucidated a key role of
5-HT in b-cells but also may contribute to change more general
concepts about monoamine functions, adding another posttrans-
lational modification to the repertoire of signaling.
Materials and Methods
Animal Experiments
Animals were held under standardized conditions on a mixed
genetic 129/SvEvBrd 6 C57BL/6 background as previously
described [13,25]. In order to ensure that Tph12/2 and Tph1+/+
do not genetically drift away from each other, they were
periodically interbred to obtain Tph1+/2, which were then used
to re-establish Tph12/2 and Tph1+/+ to refresh the breeding
colony, as generally recommended for mixed genetic backgrounds
[41]. At the beginning of physiological experiments, the mice were
at the F11-generation of interbreeding. In addition, Tph12/2
were backcrossed to the inbred strain C57BL/6 until the F8-
generation and compared with the mixed genetic background. All
phenotypical aspects were the same in the 129/SvEvBrd6C57BL/6
and the inbred C57BL/6 Tph12/2. Pancreas extracts and whole
blood samples for the determination of 5-HT contents were
obtained and analyzed as described [25,42]. For glucose and
insulin measurements, blood of barbital sodium-anaesthetized
animals was obtained from the vena cava inferior, the retrobulbar
plexus, or by severing the tail tips. Glucose was immediately
measured using a B-glucose analyzer (HemoCue) and insulin in
serum or cell culture supernatants was quantified by insulin ELISA
(Mercodia). Mice were fasted for 24 h prior to tolerance tests.
Glucose (2 g kg21), insulin (0.75 U kg21), 5-HT (4 mg kg21) or
pargyline (75 mg kg21) was injected intraperitoneally. Blood for
serum preparation was collected from the vena cava inferior as
described [13]. The serological analysis was performed at the
animal clinic laboratory VetMedLab GmbH, Division of IDEXX
Laboratories Inc. (Ludwigsburg, Germany). Peripheral 5-HT levels
for rescue experiments were replenished by subcutaneous injections
with 5-HTP as described [11].
Pancreas Slices, Immunostaining, and Electrophysiology
The agarose embedded tissue (Seaplaque GTG agarose, BMA,
Walkersville) was cut to 140 mm thick slices. During slicing and
after the preparation, the tissue was kept in an ice-cold
extracellular solution (125 mM NaCl, 2.5 mM KCl, 26 mM
NaHCO3, 1.25 mM Na2HPO4, 2 mM sodiumpyruvate, 0.25 mM
ascorbic acid, 3 mM myo-inositol, 6 mM lactic acid, 1 mM
MgCl2, 2 mM CaCl2 and 3 mM glucose) adjusted to pH 7.3 by
gassing with carbogen (95% O2, 5% CO2) for at least 30 min. The
slices were transferred to carbogen-bubbled extracellular solution
at 32uC 30 min before experiments. For primary b-cell culture,
liberase (0.3 g L21) (Roche) was dissolved in HBSS (Invitrogen)
and injected into pancreas via the bile duct. The pancreas was
removed and digested for 10–15 min at 37uC, centrifuged, and
then hand picked [43]. Isolated islets were trypsinized into single
cells, plated onto coverslips, and cultured in RPMI 1640 medium
supplemented with 10% fetal bovine serum (Invitrogen) and
antibiotics. The cultured b-cells were used within 3 d. For
immunostaining, cells were incubated overnight at 4uC with
anti-insulin and anti-S100 antibodies followed by anti-mouse
Alexa 488 and anti-rabbit Alexa 647 for 1 h at room temperature.
The fluorescence was acquired using a confocal microscope (Leica
TCS SP2 AOBS) at 488 and 633 nm. The images were processed
for morphometrical analysis using Leica confocal software.
Pancreatic b-cells were identified by the characteristic half
maximal inactivation of voltage-activated Na+ currents (approx.
2100 mV) [44]. The pipette filling solution used in depolarization
protocols, isolation of Ca2+ currents and current-clamp experi-
ments on b-cells in slices contained 127 mM Cs-methanesulfonate,
8 mM CsCl, 10 mM Hepes (pH 7.2; CsOH), 2 mM MgCl2,
0.05 mM EGTA, 20 mM TEACl, and 4 mM ATP-Na2 (see [44]
for details of the analysis). The pipette filling solution used in
photo-release experiments on isolated b-cells contained 125 mM
CsCl, 40 mM Hepes (pH 7.2; CsOH), 2 mM MgCl2, 0.05 mM
EGTA, 20 mM TEACl, 2 mM ATP-Na2, 5 mM NP-EGTA
(Molecular Probes), 4.5 mM CaCl2, and 0.1 mM Fura-6 (Molec-
ular Probes). The perfusion chamber was mounted on an upright
microscope (660 water, NA 0.9, Eclipse E600FN, Nikon, Japan).
All experiments were performed on a SWAM II C dual-phase
lock-in patch-clamp amplifier (Celica, Ljubljana). Data were
filtered at 3 kHz by an A/D converter (National Instruments).
Recording, stimulation, and preliminary analysis were performed
using the WinWcp software (v3.52, John Dempster, University of
Strathclyde, UK). Patch pipettes were pulled (P-97; Sutter
Instruments, USA) from borosilicate glass capillaries (GC150F-
15; WPI, USA) to a resistance of 2–5 MV in pipette solution as
reported previously. All currents were analyzed and presented
after p/n leak subtraction. To estimate changes in membrane
capacitance, the piecewise linear technique was used (1.6 kHz
sine-wave frequency, 11 mV RMS amplitude). Secretory activity
was triggered by elevations of cytosolic Ca2+. To manipulate Ca2+,
we used depolarizing trains or continuous photo-release (Poly-
chrome IV, Till Photonics) of caged Ca2+ (NP-EGTA). For data
analysis and figure preparation, we used Matlab, Matview (Matlab
WinWCP extension, Wise Technologies, Ljubljana), Sigmaplot,
and Sigmastat (SPSS, Chicago, IL, USA).
Cell Culture
Rat insulinoma cell line INS-1 was a generous gift from
Claes B. Wollheim (University Medical Center, Geneva), and
mouse MIN-6 cells were kindly provided by Franz Schaefer
(University Heidelberg) and cultured as described [31,32].
RINm5F cells were grown as previously described [45] in
RPMI1640 (Invitrogen) containing 11.1 mM glucose supplement-
ed with 10% fetal bovine serum (Biochrom) and antibiotics.
Insulin Secretion Assays
Insulinoma cells were cultured in Primaria plates (Falcon) 72 h
before the experiment and pretreated with 5-HTP, pargyline, or
cysteamine as indicated in the figure legends. The cells were washed
twice in glucose-free growth medium supplemented with dialyzed
serum to remove 5-HT and sensitized to glucose for 30 min in
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glucose-free medium and stimuli. Next, cells were stimulated for
60 min with or without 25 mM glucose in KRBH (136 mM NaCl,
4.7 mM KCl, 1.2 mM MgSO4, 1 mM CaCl2, 1.2 mM KH2PO4,
5 mM NaHCO3, 10 mM HEPES, and 0.5% BSA, pH 7.4) in
presence of indicated stimuli. We used KRBH to avoid any
disturbances by compounds present in normal medium and/or
serum (e.g., 5-HT). The supernatant was collected, centrifuged, and
used for insulin ELISA as described above.
Molecular Biological and Analytical Methods
All cloning procedures, PCR, and immunoblotting were
conducted according to standard protocols or to the manufactur-
er’s instructions. 6xH-Rab constructs were generated using Rab3a
and Rab27a cDNAs [13] that were reamplified with 59-primers
containing an ATG within a Kozak consensus sequence followed
by six histidine codons and a stretch of 22 specific nucleotides for
each cDNA. Stable transfection of RINm5F cells was conducted
with linearized constructs and the transfectants were selected at
50 mg mL21 G418 for at least 4 wk.
Quantitative Serotonylation Assay
TGase-mediated 5-HT protein incorporation was assessed
culturing confluent 12 well tissue culture plates for the indicated
period in the presence of 1 mCi [3H]-5-HT. After harvesting and
three extensive washing steps with PBS, the cells were homogenized
in ice-cold 300 mM PCA. Protein was collected by centrifugation
and the supernatant was measured in a scintillation counter
(Beckman) in 5 mL ReadyProtein scintillation cocktail (Beckman)
to assess for the total [3H]-5-HT uptake. The protein pellets were
washed four times with 300 mM PCA, boiled in 200 mL 10% SDS,
and sample radioactivity was determined as above. Quantitative
affinity precipitations were performed with cells grown in glucose-
stimulation medium for 4 h in the presence of 1 mCi [3H]-5-HT.
Lysates were obtained with Ni-NTA lysis buffer pH 8.0 (50 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole, protease inhibitors
w/o EDTA, 1% NP40, 1% Triton X-100, and 0.1% SDS). After
separation of the debris by centrifugation, binding of 6xH-tagged
Rabs was conducted with an excess of Ni-NTA magnetic beads
(Qiagen; 20 mL beads/cells harvested from a confluent 12 well
tissue culture cavity) and overhead turning at 4uC overnight. The
beads were then washed three times (50 mM NaH2PO4 pH 8.0,
300 mM NaCl, 8 mM imidazole, protease inhibitors w/o EDTA,
and 0.05% Tween 20) and used for quantification as above.
Statistical Analyses
All data are presented as mean 6 SEM and p values are from
two-tailed Student’s t tests type 3. Values of p,0.05 were
considered as statistically significant.
Supporting Information
Figure S1 Tph12/2 mice are hypersensitive to the
satiety mediating effect of systemically applied 5-HT. (A)
The central satiating effect of fenfluramine is normal. A dose of
1 mg kg21 body weight was ineffective, whereas 3 mg kg21
reduced food intake in a 2 h meal in both groups. (B) Peripheral
effects of 5-HT differ between wt and Tph12/2 mice in a 1 h
meal, pointing to a deregulated peripheral food intake regulation
in the latter. *p,0.05; n=11 to 13 per group. Data are presented
as means 6 SEM.
Found at: doi:10.1371/journal.pbio.1000229.s001 (0.52 MB EPS)
Figure S2 Diabetes mellitus and b-cell dysfunction in
Tph12/2mice of two different genetic backgrounds. (A–
C) Glucose tolerance test of 35–38-wk-old Tph12/2 and wt mice
(C57BL/66129SvEvBrd intercross F11-generation). The shown
data are from two independent experiments conducted with n=9
and n=6 mice per genotype. *p,0.05. (A) The fasting glucose
levels are significantly elevated in these mice as compared to their
wt littermates (9.1 versus 5.9 mM). Tph12/2 mice have also
strongly elevated glucose levels after 30 min in glucose tolerance
tests (2 g kg21). (B) Fasting insulin levels are also significantly
elevated but the insulin secretion in response to a glucose load was
significantly shortened in Tph12/2 mice (best seen at the
difference). (C) Glucose to insulin ratios are significantly increased
after the glucose load, indicating a b-cell dysfunction. (D and E) A
similar b-cell dysfunction and diabetes mellitus is seen in 12-wk-
old Tph12/2 C57BL/6 backcross F8-generation mice. The
experiment was conducted with n=9 (wt) and n=7 (Tph12/2)
mice. *p,0.05. Data are presented as means 6 SEM.
Found at: doi:10.1371/journal.pbio.1000229.s002 (0.81 MB EPS)
Figure S3 Biosynthesis and catabolism of 5-HT both
offer possibilities to manipulate intracellular 5-HT
contents. (A) Application of the immediate 5-HT precursor
5-HTP bypasses the rate-limiting step of hydroxylation. In the
cytoplasm, 5-HTP is rapidly converted to 5-HT by aromatic amino
acid decarboxlase (AAAD). Monoamine oxidase (MAO) inhibitors
impede the first step of the catabolism via 5-hydroxyindole
acetaldehyde to 5-hydroxyindole acetic acid, leading to an accumu-
lation of freshly synthesized 5-HT. (B) 5-HTP significantly elevates
whole blood 5-HT levels in Tph12/2 mice. Subcutaneous injections
with 5-HTP (50 mg kg21) were performed twice a day for 3 d. The
experiment was conducted with n=8 (wt and Tph12/2 + 5-HTP)
and n=6 (Tph12/2) mice. *p,0.005. Data are means 6 SEM.
Found at: doi:10.1371/journal.pbio.1000229.s003 (0.61 MB EPS)
Figure S4 5-HTP and pargyline largely increase intra-
cellular 5-HT content. RINm5F insulinoma cells were
incubated in the presence of 500 mM 5-HTP or 20 mM pargyline
for 4 h. After harvesting and three extensive washing steps, cells
were homogenized in ice cold 300 mM PCA and analyzed
for 5-HT metabolite content by reversed-phase HPLC. 5-HIAA,
5-hydroxyindole acetic acid. *p,0.05; n=6. Data are presented as
means 6 SEM.
Found at: doi:10.1371/journal.pbio.1000229.s004 (0.57 MB EPS)
Figure S5 VDCC stimulation, gap junctions, size, and
HVA inward current component of Tph12/2 b-cells are
normal in Tph12/2 pancreas slices, while LVA currents
are increased. (A) Peak amplitude of HVA Ca2+ currents
(VACC) elicited by square pulse stimulation to210 mV (Tph1+/+:
n=25; Tph12/2: n=18). Data are means 6 SEM. (B) Whole-cell
Ca2+ currents of Tph1+/+ (n=24) and Tph12/2 (n=19) b-cells
evoked by voltage ramps ranging from290 to +50 mVwith duration
of 300 ms (0.47 mV ms21). The application of this protocol resulted
in the separation of two inward current components, showing peaks
around230 and25 mV, which most likely correspond to LVA and
HVA Ca2+ currents. Data are presented as means. (C) Electrical
coupling between the whole-cell patch-clamped b-cell and its
immediate neighboring b-cell (Tph1+/+: n=25; Tph12/2: n=18).
Data are means 6 SEM. (D) The resting membrane capacitance
is a measure of the b-cell membrane surface area and does
not differ significantly between the genotypes (Tph1+/+: n=25;
Tph12/2: n=18). Data are means 6 SEM.
Found at: doi:10.1371/journal.pbio.1000229.s005 (0.65 MB EPS)
Figure S6 5-HT restores slow component of Ca2+-
dependent exocytosis of Tph12/2 b-cells. (A) Amplitude
of the fast component of the membrane capacitance change of
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single b-cells stimulated by ramp [Ca2+]i change. (B) Amplitude of
the slow component of the membrane capacitance change.
*p,0.05; **p,0.01. (C) Peak intracellular Ca2+ concentration
during slow photo-release of NP-EGTA-caged Ca2+. Experiments
were performed with n=15 (Tph12/2), n=12 (Tph12/2 +
5-HTPe), n=7 (Tph12/2 + 5-HTi, and n=19 (wt). All data are
presented as means 6 SEM.
Found at: doi:10.1371/journal.pbio.1000229.s006 (0.69 MB EPS)
Figure S7 Cysteamine inhibits protein serotonylation
and reduces insulin secretion. (A) Insulin secretion from
RINm5F cells stimulated with 25 mM glucose in the presence of
cysteamine (CTA; 500 mM; 3 h). *p,0.05; n=3. Shown are
combined data of three experiments conducted in quadruplicate.
(B) Insulin secretion from INS-1 cells stimulated with 25 mM
glucose in the presence of CTA (500 mM; 3 h). *p,0.05; n=4.
Data are means 6 SEM.
Found at: doi:10.1371/journal.pbio.1000229.s007 (0.52 MB EPS)
Figure S8 Quantitative Ni-NTA affinity precipitation of
his-tagged Rabs from lysates of RINm5F cells stably
transfected with corresponding constructs. Immunoblot-
ting demonstrates that the overexpressed proteins of the lysates
(1/200th of input) are quantitatively precipitated, since AP superna-
tants (1/200th of input) lack the specific immuno-reactive bands,
which are present in the lysates and largely enriched in the washed
beads fractions (1/5th of total yield).
Found at: doi:10.1371/journal.pbio.1000229.s008 (1.06 MB TIF)
Figure S9 The insulinoma cell lines b-TC3 and RINm5F
express all components required for serotonylation in
the insulin-secreting machinery. Immunoblotting of cell
lysates with commercially available antibodies. VMAT2, vesicular
monoamine transporter 2.
Found at: doi:10.1371/journal.pbio.1000229.s009 (2.78 MB TIF)
Table S1 Serological parameters of Tph12/2mice. The
pancreas indicators a-amylase and lipase are normal. The elevated
liver values are in line with our previous report about deficient
liver regeneration capacity in Tph12/2 [11].
Found at: doi:10.1371/journal.pbio.1000229.s010 (0.04 MB
DOC)
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